DrugDashboards

furosemide

furosemide · FUROSEMIDE 8 mg/mL · Injection · ten23 health Valais AG

NDC 83284-0002-01 · 6 BOX in 1 CARTON / 30 CARTRIDGE in 1 BOX / 10 mL in 1 CARTRIDGE · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.6%chance of a new FDA shortage posting for furosemide (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · price up 19% YoY

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $6.22 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
—
TE code
—
Approval date
—
Patents / exclusivity
—

Shortage history

  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08)Apr 7, 2020
    Requirements related to complying with good manufacturing practices
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43)Apr 7, 2020
    Requirements related to complying with good manufacturing practices
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43)Apr 7, 2020
    Requirements related to complying with good manufacturing practices
    month 77 — 4× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of furosemide (Injection)

LabelerStrengthFirst seenLast seen
Hikma Pharmaceuticals USA Inc.FUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Maiva Pharma Private LimitedFUROSEMIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals LLCFUROSEMIDE 20 mg/2mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCFUROSEMIDE 40 mg/4mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCFUROSEMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
Civica, Inc.FUROSEMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCFUROSEMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLC.FUROSEMIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Micro Labs LimitedFUROSEMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
Micro Labs LimitedFUROSEMIDE 20 mg/2mLJul 15, 2026Sep 2, 2026
Micro Labs LimitedFUROSEMIDE 40 mg/4mLJul 15, 2026Sep 2, 2026
scPharmaceuticals Inc., a wholly owned subsidiary of MannKind CorporationFUROSEMIDE 80 mg/mLJul 29, 2026Sep 2, 2026
SQ Innovation, Inc.FUROSEMIDE 30 mg/mLJul 15, 2026Sep 2, 2026
ten23 health Valais AGFUROSEMIDE 8 mg/mLJul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.FUROSEMIDE 10 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "furosemide — NDC 83284-0002-01," retrieved September 3, 2026, https://drugdashboards.com/drug/83284000201.

Free to cite with attribution — see how the data is put together.